BPC-157 Capsules
Refilling Soon
This peptide is currently out of stock. Get notified the moment it's available.
About BPC-157 Capsules
BPC-157 Capsules deliver the same HPLC-verified pentadecapeptide as injectable vials in an oral format specifically investigated for gastrointestinal and systemic applications. Research into oral BPC-157 has centred on its gastroprotective properties — studies in rodent models have consistently demonstrated its ability to accelerate healing of gastric ulcers, protect the gastric mucosa against NSAID-induced damage, and modulate the enteric nervous system. Unlike the injectable form, oral BPC-157 is thought to exert its primary effects locally within the GI tract before entering systemic circulation, making it a compelling subject for gut health and IBD mechanism research. Secondary systemic effects on inflammation and connective tissue repair have also been reported following oral administration, suggesting partial bioavailability through the GI epithelium. Each capsule contains precisely measured, lyophilised BPC-157 manufactured to ≥99% HPLC purity, with certificate of analysis available for every batch.
Usage Guidelines
✓ Suitable For
- Suitable for gut health and gastrointestinal repair research protocols
- Ideal for researchers requiring oral (non-injectable) administration routes
- Well characterised in rodent IBD and gastropathy models
- Store capsules in a cool dry environment away from light and humidity
✗ Not Recommended For
- Not recommended for use without professional research supervision
- Not for human consumption outside of approved research protocols
- Do not use if you have known hypersensitivity to any peptide compounds
- Consult relevant ethics committee guidelines before in vivo research